Yahoo Web Search

Search results

    • Is CRISPR Therapeutics Stock a Buy?

      Is CRISPR Therapeutics Stock a Buy?

      Motley Fool via Yahoo Finance· 1 hour ago

      Those are both marketed by Bluebird Bio, a small biotech company that exited the European market a few years ago. And while there are several more...

    • Health Care Roundup: Market Talk

      Health Care Roundup: Market Talk

      The Wall Street Journal· 3 hours ago

      Roche disclosed its weight-loss drug candidate CT-388 had achieved positive results in an early-stage trial. The phase 1 trial comes amidst a race for a...